BIGBEAR
PHARMACEUTICAL
Binimetinib is a targeted anti-cancer drug that works by blocking the MEK protein (a key protein that stimulates cancer cell growth) within cancer cells, thereby inhibiting tumor growth.
AuthenticGuaranteeFast DeliveryPrivacy Binimetinib is an antineoplastic agent that inhibits mitogen-activated extracellular signal-regulated kinases MEK1 and MEK2.Binimetinib Precautions1. ···【More】
Update: 24 Jul,2026Source: BigbearViews: 83
During treatment with Binimetinib, different side effects may occur. If you have limited knowledge about the side effects of Binimetinib, please consu···【More】
Update: 24 Jul,2026Source: BigbearViews: 84
Dose Adjustments for Specific Adverse Reactions of Binimetinib1. Cardiomyopathy(1) Asymptomatic decrease in left ventricular ejection fraction (LVEF) ···【More】
Update: 24 Jul,2026Source: BigbearViews: 81
Binimetinib usual dose is 45 mg twice daily. Binimetinib is used in combination with Encorafenib for metastatic melanoma and non-small cell lung cance···【More】
Update: 24 Jul,2026Source: BigbearViews: 83
On June 27, 2018, the U.S. Food and Drug Administration (FDA) approved the combination regimen of Binimetinib and Encorafenib for the treatment of pat···【More】
Update: 12 May,2026Source: BigbearViews: 168
October 12, 2023 – New York – (Business Wire)Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi®···【More】
Update: 12 May,2026Source: BigbearViews: 143
Binimetinib is indicated for use in combination with encorafenib for the treatment of advanced melanoma and non-small cell lung cancer (NSCLC) harbori···【More】
Update: 12 May,2026Source: BigbearViews: 136
In June 2018, the U.S. Food and Drug Administration (FDA) approved binimetinib for marketing as a treatment for unresectable metastatic melanoma or me···【More】
Update: 05 Mar,2026Source: BigbearViews: 138
Binimetinib, developed by Pierre Fabre in France, was approved by the U.S. Food and Drug Administration (FDA) in 2018, providing a new treatment optio···【More】
Update: 04 Mar,2026Source: BigbearViews: 135
Binimetinib is often used in combination with encorafenib. These two drugs target the same signaling pathway at different points and can synergistical···【More】
Update: 04 Mar,2026Source: BigbearViews: 124
While binimetinib offers a new treatment option for melanoma patients, its potential adverse reactions still require careful monitoring during use.Sid···【More】
Update: 04 Mar,2026Source: BigbearViews: 123
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
